Literature DB >> 33180333

A Novel GNAS Duplication Associated With Loss-of-Methylation Restricted to Exon A/B Causes Pseudohypoparathyroidism Type Ib (PHP1B).

Monica Reyes1, Masayo Kagami2, Sayaka Kawashima2, Johanna Pallotta3, Dirk Schnabel4, Maki Fukami2, Harald Jüppner1,3.   

Abstract

Pseudohypoparathyroidism type Ib (PHP1B) is characterized by resistance to parathyroid hormone (PTH) leading to hypocalcemia and hyperphosphatemia, and in some cases resistance toward additional hormones. Patients affected by this disorder all share a loss-of-methylation (LOM) at the differentially methylated GNAS exon A/B, which reduces expression of the stimulatory G protein α-subunit (Gsα) from the maternal allele. This leads in the proximal renal tubules, where the paternal GNAS allele does not contribute much to expression of this signaling protein, to little or no Gsα expression thereby causing PTH resistance. We now describe a PHP1B patient with a de novo genomic GNAS duplication of approximately 88 kb, which is associated with LOM restricted to exon A/B alone. Multiplex ligation-dependent probe amplification (MLPA), comparative genomic hybridization (CGH), and whole-genome sequencing (WGS) established that the duplicated DNA fragment extends from GNAS exon AS1 (telomeric breakpoint) to a small region between two imperfect repeats just upstream of LOC105372695 (centromeric breakpoint). Our novel duplication is considerably shorter than previously described duplications/triplications in that portion of chromosome 20q13 and it does not affect methylation at exons AS and XL. Based on these and previous findings, it appears plausible that the identified genomic abnormality disrupts in cis the actions of a transcript that is required for establishing or maintaining exon A/B methylation. Our findings extend the molecular causes of PHP1B and provide additional insights into structural GNAS features that are required for maintaining maternal Gsα expression and for preventing PTH-resistance.
© 2020 American Society for Bone and Mineral Research (ASBMR). © 2020 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  CELL/TISSUE SIGNALING; DISORDERS OF CALCIUM/PHOSPHATE METABOLISM; ENDOCRINE PATHWAYS; EPIGENETICS; GENETIC RESEARCH; PARATHYROID-RELATED DISORDERS; PTH/Vit D/FGF23

Mesh:

Substances:

Year:  2020        PMID: 33180333      PMCID: PMC8048081          DOI: 10.1002/jbmr.4209

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  35 in total

1.  A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gsα Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B).

Authors:  Giedre Grigelioniene; Pasi I Nevalainen; Monica Reyes; Susanne Thiele; Olta Tafaj; Angelo Molinaro; Rieko Takatani; Marja Ala-Houhala; Daniel Nilsson; Jesper Eisfeldt; Anna Lindstrand; Marie-Laure Kottler; Outi Mäkitie; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2017-02-24       Impact factor: 6.741

Review 2.  The role of GNAS and other imprinted genes in the development of obesity.

Authors:  L S Weinstein; T Xie; A Qasem; J Wang; M Chen
Journal:  Int J Obes (Lond)       Date:  2009-10-20       Impact factor: 5.095

3.  Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib.

Authors:  Murat Bastepe; Leopold F Fröhlich; Agnès Linglart; Hilal S Abu-Zahra; Katsuyoshi Tojo; Leanne M Ward; Harald Jüppner
Journal:  Nat Genet       Date:  2004-12-12       Impact factor: 38.330

4.  A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.

Authors:  J Liu; D Litman; M J Rosenberg; S Yu; L G Biesecker; L S Weinstein
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR.

Authors:  Francesca M Elli; Luisa de Sanctis; Erika Peverelli; Paolo Bordogna; Barbara Pivetta; Gianmaria Miolo; Paolo Beck-Peccoz; Anna Spada; Giovanna Mantovani
Journal:  J Clin Endocrinol Metab       Date:  2014-01-17       Impact factor: 5.958

6.  The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding.

Authors:  Antonius Plagge; Emma Gordon; Wendy Dean; Romina Boiani; Saverio Cinti; Jo Peters; Gavin Kelsey
Journal:  Nat Genet       Date:  2004-07-25       Impact factor: 38.330

7.  Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.

Authors:  Francesca M Elli; Luisa de Sanctis; Valentina Bollati; Letizia Tarantini; Marcello Filopanti; Anna Maria Barbieri; Erika Peverelli; Paolo Beck-Peccoz; Anna Spada; Giovanna Mantovani
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

8.  A novel long-range deletion spanning STX16 and NPEPL1 causing imprinting defects of the GNAS locus discovered in a patient with autosomal-dominant pseudohypoparathyroidism type 1B.

Authors:  Yi Yang; Xueying Chu; Min Nie; An Song; Yan Jiang; Mei Li; Weibo Xia; Xiaoping Xing; Ou Wang
Journal:  Endocrine       Date:  2020-04-26       Impact factor: 3.633

9.  Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b.

Authors:  Stéphanie Maupetit-Méhouas; Salah Azzi; Virginie Steunou; Nathalie Sakakini; Caroline Silve; Christelle Reynes; Guiomar Perez de Nanclares; Boris Keren; Sandra Chantot; Anne Barlier; Agnès Linglart; Irène Netchine
Journal:  Hum Mutat       Date:  2013-05-28       Impact factor: 4.878

10.  Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus.

Authors:  Gustavo Perez-Nanclares; Teresa Velayos; Amaya Vela; Manuel Muñoz-Torres; Luis Castaño
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

View more
  5 in total

1.  Lack of GNAS Remethylation During Oogenesis May Be a Cause of Sporadic Pseudohypoparathyroidism Type Ib.

Authors:  Angelo Milioto; Monica Reyes; Patrick Hanna; Zentaro Kiuchi; Serap Turan; Daniel Zeve; Chhavi Agarwal; Giedre Grigelioniene; Ang Chen; Veronica Mericq; Myrto Frangos; Svetlana Ten; Giovanna Mantovani; Isidro B Salusky; Peter Tebben; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

2.  Targeted Long-Read Sequencing Identifies a Retrotransposon Insertion as a Cause of Altered GNAS Exon A/B Methylation in a Family With Autosomal Dominant Pseudohypoparathyroidism Type 1b (PHP1B).

Authors:  Danny E Miller; Patrick Hanna; Miranda Galey; Monica Reyes; Agnès Linglart; Evan E Eichler; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2022-08-03       Impact factor: 6.390

Review 3.  Molecular Definition of Pseudohypoparathyroidism Variants.

Authors:  Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

4.  A novel deletion involving the first GNAS exon encoding Gsα causes PHP1A without methylation changes at exon A/B.

Authors:  Devon Campbell; Monica Reyes; Sare Betul Kaygusuz; Saygın Abali; Tulay Guran; Abdullah Bereket; Masayo Kagami; Serap Turan; Harald Jüppner
Journal:  Bone       Date:  2022-01-29       Impact factor: 4.626

5.  High-throughput Molecular Analysis of Pseudohypoparathyroidism 1b Patients Reveals Novel Genetic and Epigenetic Defects.

Authors:  Jennifer Danzig; Dong Li; Suzanne Jan de Beur; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.